Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.21
売上高対価格比率
0.24
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4372 | ALGS Aligos Therapeutics, Inc. - Common stock | 5.80 USD | -1.02% | -17.26% | +35.20% | -40.76% | 36.17 M USD | ||
| 4374 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 USD | -1.32% | +21.95% | +31.58% | -63.24% | 36.02 M USD | ||
| 4382 | CNTX Context Therapeutics Inc. - Common Stock | 0.37 USD | -5.13% | -19.57% | -40.32% | -56.47% | 34.00 M USD | ||
| 4386 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.30 USD | +9.52% | -15.44% | -49.12% | -75.81% | 38.94 M USD |